PNC Financial Services Group’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $68.7K | Buy |
3,935
+25
| +0.6% | +$436 | ﹤0.01% | 2935 |
|
|
2025
Q1 | $49.2K | Buy |
3,910
+3,905
| +78,100% | +$49.1K | ﹤0.01% | 3102 |
|
|
2024
Q4 | $53 | Buy |
+5
| New | +$53 | ﹤0.01% | 4734 |
|
|
2024
Q2 | – | Sell |
-8
| Closed | -$82 | – | 4911 |
|
|
2024
Q1 | $82 | Hold |
8
| – | – | ﹤0.01% | 4649 |
|
|
2023
Q4 | $44 | Buy |
+8
| New | +$44 | ﹤0.01% | 4574 |
|